Category: Oregon Regulation and Legislation
-
Court Sets Date: Cusker et al. v. OHA Heads to Oral Argument on November 16
The National Psychedelics Association announced a pivotal court hearing on November 16, 2026, addressing psilocybin accessibility for disabled and terminally ill Oregonians, crucial for shaping future service programs.
-
Oregon OHA Drops Psilocybin Fee Increases
September 22, 2026 This morning, the Oregon Health Authority made it official: the proposed psilocybin rule-making that would have sharply increased licensing fees is dead. OHA will not be moving forward with the rules identified in its August 28, 2026 Notice of Proposed Rulemaking, which means the fee increases at the heart of that package…
-
Public Testimony Against Rising Psilocybin Fees in Oregon
At a public hearing, stakeholders expressed overwhelming opposition to proposed fee increases for Oregon’s psilocybin services program, arguing that these would worsen budget shortfalls and reduce access. Testimonies highlighted concerns about the financial viability for facilitators and the risk of driving them out of the regulated market, potentially harming clients who rely on these services.
-
From the Road to PS25
The National Psychedelics Association (the NPA) hits the road: lessons from Oregon’s trailblazers As the first state to roll out legal psilocybin-based care, Oregon is home to pioneers in Psychedelic-Assisted Care (PAC). At the NPA, we spent the end of 2024 visiting our member service centers across the state, gathering powerful stories, hard-earned insights, and…
-
The Intersection of End of Life Issues and the Oregon Psilocybin Services Act
Oregon’s Psilocybin Services Act (“PSA”) is the first state law legalizing access to psilocybin for adults. Psilocybin remains illegal to manufacture, distribute, dispense or possess under the federal Controlled Substances Act. Those with terminal illness are one population known to benefit particularly from psilocybin therapy. Clinical trials have shown that patients with advanced cancer may…
-
Avenues to Access Psilocybin Therapy in Oregon, a New Palliative Care Tool for Patients Suffering Anxiety and Depression
Recent medical research is establishing the powerful therapeutic uses of psilocybin in the treatment of anxiety and depression suffered by patients with terminal illness, as well as other possible indications. Studies show that patients with advanced cancer suffering from treatment-resistant anxiety and/or depression experienced significant reductions in both anxiety and depression and improvements of mood…
-
Cooperative Federalism Returns with the Biden Administration: Implications for Cannabis as well as Psilocbyin
In November 2020, Oregon voters approved a first of its kind initiative to make psilocybin therapy legal under Oregon state law. The Oregon Psilocybin Services Act (PSA) is heavily regulatory, establishing a two year ‘development period’ for development of regulations by the Oregon Health Authority (OHA), advised by a Psilocybin Advisory Board to be established…